CellCgen package
Regeneration

CellCGen

Exosome & HA Medical Device

Type
Regeneration skin booster
Brand
BREXOGEN
Pack
2g × 2 syringes per box
MOQ
10 boxes
Origin
Made in Korea
Shipping
FCA Korea (Incoterms 2020)
Category
Professional aesthetic medical device
Format
Sterile prefilled syringe
Package Contents
2g × 2 syringes per box

Key actives

  • Exosome-based ingredients
  • Hyaluronic Acid (HA)
  • exosome
  • exosome-based aesthetic medical device
Place an orderMOQ 10 boxes · our trade team replies within one business day

Genuine productsSourced directly from Korean manufacturers.

Shipping documents with every orderCommercial invoice (INV) and packing list (PKG), ready for customs clearance.

Checked before dispatchProducts and export documents are verified before shipping.

About this booster

CellCGen is a Korean regeneration skin booster with Exosome-based ingredients, Hyaluronic Acid (HA), exosome and exosome-based aesthetic medical device.

Pack
2g × 2 syringes per box
Minimum order
10 boxes

CellCGen is exosome-based aesthetic medical device developed by BREXOGEN, combining high-content exosome ingredients with Hyaluronic Acid (HA).

Designed for professional medical-aesthetic environments, CellCGen is supplied in a sterile, single-use prefilled syringe format.

The manufacturer positions CellCGen as a comprehensive skin-focused product targeting the appearance of fine lines, uneven skin texture, reduced elasticity, and dull-looking skin.

According to BREXOGEN's product documentation, CellCGen is classified as a Class II medical device in South Korea. Its approved indications, application methods, and distribution eligibility must be confirmed for each destination market.

Key Features & Benefits

  • Exosome-Based Technology: Developed using BREXOGEN's proprietary exosome platform.
  • Exosome + HA Combination: Features exosome-based ingredients and hyaluronic acid.
  • Professional Aesthetic Focus: Positioned for skin appearance, hydration, texture, and age-related aesthetic concerns.
  • Prefilled Syringe Format: Supplied in a convenient professional-use configuration.
  • Sterile, Single-Use Packaging: Designed for one-time use according to the manufacturer's documentation.
  • Korean Medical Device Classification: Described by BREXOGEN as a Korean Class II medical device.

Key Ingredients

  • Exosome-based ingredients
  • Hyaluronic Acid (HA)

Export documents

With every order

  • Commercial invoice (INV)
  • Packing list (PKG)

Available on request

  • Certificate of Analysis (CoA)
  • MSDS / SDS
  • Certificate of Free Sale (CFS)
  • Certificate of Origin

Shipping documents are prepared for customs clearance in your country. Ask for any document on request with your quote.

How importing works, country by country

Questions about CellCGen

1. What is CellCGen?

CellCGen is an exosome and hyaluronic acid-based medical device developed by BREXOGEN in South Korea. It is supplied in a sterile, single-use prefilled syringe format for professional use under the applicable regulatory framework.

2. Is CellCGen a Korean Class II medical device?

BREXOGEN's product documentation describes CellCGen as a Korean Class II medical device. Buyers should confirm the applicable registration documentation and approved indications before purchase or distribution.

3. Is CellCGen an injectable product?

A prefilled syringe format does not by itself establish an approved injection route. The appropriate administration method must be determined from the product's official instructions for use and local regulatory authorization.

4. How many syringes are included in one box?

The manufacturer's product comparison table lists two prefilled syringes containing 2g each per box.

5. Can CellCGen be distributed internationally?

International distribution depends on the product's regulatory status, import requirements, labeling, and professional-use restrictions in each country. Korean medical device classification does not automatically constitute approval in other markets.

More Regeneration boosters